Paul R Kirchgraber - Net Worth and Insider Trading
Paul R Kirchgraber Net Worth
The estimated net worth of Paul R Kirchgraber is at least $3 Million dollars as of 2024-06-09. Paul R Kirchgraber is the CEO, Covance Drug Development of Labcorp Holdings Inc and owns about 12,946 shares of Labcorp Holdings Inc (LH) stock worth over $3 Million. Details can be seen in Paul R Kirchgraber's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul R Kirchgraber has not made any transactions after 2023-05-19 and currently still holds the listed stock(s).
Transaction Summary of Paul R Kirchgraber
Paul R Kirchgraber Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul R Kirchgraber owns 1 companies in total, including Labcorp Holdings Inc (LH) .
Click here to see the complete history of Paul R Kirchgraber’s form 4 insider trades.
Insider Ownership Summary of Paul R Kirchgraber
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LH | Labcorp Holdings Inc | 2023-05-19 | CEO & Covance Drug Development |
Paul R Kirchgraber Latest Holdings Summary
Paul R Kirchgraber currently owns a total of 1 stock. Paul R Kirchgraber owns 12,946 shares of Labcorp Holdings Inc (LH) as of May 19, 2023, with a value of $3 Million.
Latest Holdings of Paul R Kirchgraber
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LH | Labcorp Holdings Inc | 2023-05-19 | 12,946 | 196.60 | 2,545,184 |
Holding Weightings of Paul R Kirchgraber
Paul R Kirchgraber Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul R Kirchgraber has made a total of 3 transactions in Labcorp Holdings Inc (LH) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Labcorp Holdings Inc is the sale of 4,300 shares on May 19, 2023, which brought Paul R Kirchgraber around $932,713.
Insider Trading History of Paul R Kirchgraber
- 1
Paul R Kirchgraber Trading Performance
Paul R Kirchgraber Ownership Network
Ownership Network List of Paul R Kirchgraber
Ownership Network Relation of Paul R Kirchgraber
Paul R Kirchgraber Owned Company Details
What does Labcorp Holdings Inc do?
Who are the key executives at Labcorp Holdings Inc?
Paul R Kirchgraber is the CEO & Covance Drug Development of Labcorp Holdings Inc. Other key executives at Labcorp Holdings Inc include SVP & Global General Counsel Van Der Vaart Sandra D , SVP & Chief Accounting Officer Peter J Wilkinson , and EVP & Chief Marketing Officer Amy B. Summy .
Labcorp Holdings Inc (LH) Insider Trades Summary
Over the past 18 months, Paul R Kirchgraber made 1 insider transaction in Labcorp Holdings Inc (LH) with a net sale of 4,300. Other recent insider transactions involving Labcorp Holdings Inc (LH) include a net sale of 6,846 shares made by Van Der Vaart Sandra D , a net sale of 14,067 shares made by Mark S Schroeder , and a net sale of 5,500 shares made by Kerrii B Anderson .
In summary, during the past 3 months, insiders sold 18,469 shares of Labcorp Holdings Inc (LH) in total and bought 0 shares, with a net sale of 18,469 shares. During the past 18 months, 38,263 shares of Labcorp Holdings Inc (LH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 38,263 shares.
Labcorp Holdings Inc (LH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Labcorp Holdings Inc Insider Transactions
Paul R Kirchgraber Mailing Address
Above is the net worth, insider trading, and ownership report for Paul R Kirchgraber. You might contact Paul R Kirchgraber via mailing address: 531 South Spring Street, Burlington Nc 27215.